Total Funding: $124 M
Headquarters: Hangzhou, Zhejiang, China
Funding Status: M&A
Employee Number: 51-100
Estimated Revenue: $1M to $10M
Technology: Immunotherapy
Founded Date: 01.01.2015
Industry: Early Drug Development